Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

159 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Vaccine effectiveness against SARS-CoV-2 transmission and infections among household and other close contacts of confirmed cases, the Netherlands, February to May 2021.
de Gier B, Andeweg S, Joosten R, Ter Schegget R, Smorenburg N, van de Kassteele J; RIVM COVID-19 surveillance and epidemiology team 1,; Hahné SJ, van den Hof S, de Melker HE, Knol MJ; Members of the RIVM COVID-19 surveillance and epidemiology team. de Gier B, et al. Among authors: van de kassteele j, van den hof s. Euro Surveill. 2021 Aug;26(31):2100640. doi: 10.2807/1560-7917.ES.2021.26.31.2100640. Euro Surveill. 2021. PMID: 34355689 Free PMC article.
Higher risk of SARS-CoV-2 Omicron BA.4/5 infection than of BA.2 infection after previous BA.1 infection, the Netherlands, 2 May to 24 July 2022.
Andeweg SP, de Gier B, Vennema H, van Walle I, van Maarseveen N, Kusters NE, de Melker HE, Hahné SJ, van den Hof S, Eggink D, Knol MJ. Andeweg SP, et al. Among authors: van maarseveen n, van walle i, van den hof s. Euro Surveill. 2023 Feb;28(7):2200724. doi: 10.2807/1560-7917.ES.2023.28.7.2200724. Euro Surveill. 2023. PMID: 36795499 Free PMC article.
Effectiveness of bivalent mRNA booster vaccination against SARS-CoV-2 Omicron infection, the Netherlands, September to December 2022.
Huiberts AJ, de Gier B, Hoeve CE, de Melker HE, Hahné SJ, den Hartog G, van de Wijgert JH, van den Hof S, Knol MJ. Huiberts AJ, et al. Among authors: den hartog g, van den hof s, van de wijgert jh. Euro Surveill. 2023 Feb;28(7):2300087. doi: 10.2807/1560-7917.ES.2023.28.7.2300087. Euro Surveill. 2023. PMID: 36795500 Free PMC article.
Mpox outbreak in the Netherlands, 2022: public health response, characteristics of the first 1,000 cases and protection of the first-generation smallpox vaccine.
van Ewijk CE, Miura F, van Rijckevorsel G, de Vries HJ, Welkers MR, van den Berg OE, Friesema IH, van den Berg PR, Dalhuisen T, Wallinga J, Brandwagt D, van Cleef BA, Vennema H, Voordouw B, Koopmans M, van der Eijk AA, Swaan CM, Te Wierik MJ, Leenstra T, Op de Coul E, Franz E; Dutch Mpox Response Team; Members of the Dutch Mpox Response Team. van Ewijk CE, et al. Euro Surveill. 2023 Mar;28(12):2200772. doi: 10.2807/1560-7917.ES.2023.28.12.2200772. Euro Surveill. 2023. PMID: 36951783 Free PMC article.
Time Scales of Human Mpox Transmission in The Netherlands.
Miura F, Backer JA, van Rijckevorsel G, Bavalia R, Raven S, Petrignani M, Ainslie KEC, Wallinga J; Dutch Mpox Response Team. Miura F, et al. J Infect Dis. 2024 Mar 14;229(3):800-804. doi: 10.1093/infdis/jiad091. J Infect Dis. 2024. PMID: 37014716 Free PMC article.
Vaccine effectiveness of primary and booster COVID-19 vaccinations against SARS-CoV-2 infection in the Netherlands from July 12, 2021 to June 6, 2022: A prospective cohort study.
Huiberts AJ, de Gier B, Hoeve CE, de Melker HE, Hahné SJM, den Hartog G, Grobbee DE, van de Wijgert JHHM, van den Hof S, Knol MJ. Huiberts AJ, et al. Among authors: van de wijgert jhhm, den hartog g, van den hof s. Int J Infect Dis. 2023 Aug;133:36-42. doi: 10.1016/j.ijid.2023.04.401. Epub 2023 Apr 20. Int J Infect Dis. 2023. PMID: 37086863 Free PMC article.
Effect of COVID-19 vaccination on mortality by COVID-19 and on mortality by other causes, the Netherlands, January 2021-January 2022.
de Gier B, van Asten L, Boere TM, van Roon A, van Roekel C, Pijpers J, van Werkhoven CHH, van den Ende C, Hahné SJM, de Melker HE, Knol MJ, van den Hof S. de Gier B, et al. Among authors: van den hof s. Vaccine. 2023 Jul 12;41(31):4488-4496. doi: 10.1016/j.vaccine.2023.06.005. Epub 2023 Jun 8. Vaccine. 2023. PMID: 37328352 Free PMC article.
Age-specific severity of severe acute respiratory syndrome coronavirus 2 in February 2020 to June 2021 in the Netherlands.
de Boer PT, van de Kassteele J, Vos ERA, van Asten L, Dongelmans DA, van Gageldonk-Lafeber AB, den Hartog G, Hofhuis A, van der Klis F, de Lange DW, Stoeldraijer L; RIVM COVID‐19 epidemiology and surveillance team; de Melker HE, Geubbels E, van den Hof S, Wallinga J. de Boer PT, et al. Among authors: van den hof s. Influenza Other Respir Viruses. 2023 Aug 22;17(8):e13174. doi: 10.1111/irv.13174. eCollection 2023 Aug. Influenza Other Respir Viruses. 2023. PMID: 37621921 Free PMC article.
159 results